Senator Investment Group

Suggest edits

Built with ❤︎ by Datalicious ©2018
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 3

Portfolio

Portfolio Tracker

Add info

Microsoft partners with biotech firm to create an AI-based blood test for diagnosing disease - SiliconANGLE

Health Intelligent machines

Microsoft partners with Adaptive Biotech on AI-driven blood test to diagnose dozens of diseases at once

Health Intelligent machines

$275,000,000 Venture capital (Series D)

, ,

Ginkgo Bioworks raises $275 million to bring its lab-made DNA to more industries

Science Technology Funding

via

Ginkgo Bioworks, ‘the organism company,’ is now worth over $1 billion

Funding Science

Ginkgo Bioworks Taps Transcriptic Robotics Software to Accelerate Automation

Robotics Science Technology

Acquisition

Ginkgo Bioworks Acquires Leading Synthetic DNA Provider Gen9

Ginkgo Builds Out Robot Labs as Microbe Design Business Grows: Photos

Robotics Science Apps & Services

$100,000,000 Venture capital (Series C)

, , , +1

Boston Startup Raises $100 Million To Use Synthetic Biology To Design Microbes For Industry - Forbes

Seattle’s Adaptive Bio to Base New Drug-Hunting Team in San Diego

Health Technology

Ginkgo Bioworks Adds $45M to Expand Organism Engineering

Funding Science

$45,000,000 Venture capital (Series B)

Ginkgo Bioworks Takes On Zymergen With $45 Million In Series B Funding

Science Funding

Ginkgo Bioworks Lands $9 Million In Series A Funding To Build Out New Lab Facilities

Funding Science

$94,000,000 Private equity

Index

By TNW

Senator Investment Group

Senator Investment Group

Overview

News

Investments 3

Portfolio

Portfolio Tracker

Microsoft partners with biotech firm to create an AI-based blood test for diagnosing disease - SiliconANGLE

Microsoft partners with Adaptive Biotech on AI-driven blood test to diagnose dozens of diseases at once

Ginkgo Bioworks raises $275 million to bring its lab-made DNA to more industries

Ginkgo Bioworks, ‘the organism company,’ is now worth over $1 billion

Ginkgo Bioworks Taps Transcriptic Robotics Software to Accelerate Automation

Ginkgo Bioworks Acquires Leading Synthetic DNA Provider Gen9

Ginkgo Builds Out Robot Labs as Microbe Design Business Grows: Photos

Boston Startup Raises $100 Million To Use Synthetic Biology To Design Microbes For Industry - Forbes

Seattle’s Adaptive Bio to Base New Drug-Hunting Team in San Diego

Ginkgo Bioworks Adds $45M to Expand Organism Engineering

Ginkgo Bioworks Takes On Zymergen With $45 Million In Series B Funding

Ginkgo Bioworks Lands $9 Million In Series A Funding To Build Out New Lab Facilities

Adaptive Biotechnologies acquires San Francisco immunosequencing company Sequenta - Puget Sound Business Journal